BioSpace News Archive

Analysis Group , one of the largest international economics consulting firms, has again been recognized as a leader on the Global Competition Review ( GCR ) Economics 21.

Magellan Health, Inc. (NASDAQ: MGLN) today announced that the Company’s Board of Directors has appointed David Haddock as general counsel and secretary of Magellan Health, effective Monday, February 3, 2020.

Researchers at the National Safety Council and the University of Michigan found that about 1 in 20 adolescents ages 10 to 17 and 1 in 10 young adults ages 18 to 25 report prescription opioid misuse, based on a new review published in Preventive Medicine

‘Health Care Is’ campaign will highlight EmblemHealth’s programs and initiatives focused on enlarging the concept of health

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today it has completed the previously announced acquisition of Aevi Genomic Medicine (NASDAQ: GNMX) in an all-stock transaction valued at approximately $15.6 million at close

QIAGEN N.V. announced the CE-marking and launch of its therascreen® PIK3CA RGQ PCR Kit in Europe as an aid in identifying breast cancer patients with a PIK3CA mutation.

Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced that it has launched an underwritten public offering of $500 million of its common stock.

Opportunity International and Milliman are working together to launch the first extreme poverty Opportunity Zone innovation hub in Uganda.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Merit Medical Systems, Inc. securities during the period from February 26, 2019 and October 30, 2019, inclusive..

PTC Therapeutics, Inc. announced that on January 29, 2020 it approved non-statutory stock options to purchase an aggregate of 182,150 shares of its common stock to 57 new employees.